TriNet Group (TNET) investor relations material

Executive summary

• Delivered solid financial performance in a challenging SMB environment with high medical cost inflation and muted hiring activity, finishing at the top end of earnings guidance and generating 16% free cash flow growth.

• Significant capital returned to shareholders through repurchases and dividends, with the stock repurchase program increased to $400 million.

• Strategic initiatives for 2026 include launching the AI-powered TriNet Assistant, expanding the broker channel, and forming new partnerships.

• Investments in client service, go-to-market execution, and operational efficiency are driving momentum, with sales up in January and broker channel expansion underway.

• Achieved an all-time high Net Promoter Score and will launch TriNet Assistant, an AI-powered HR tool, to further enhance client value.

Financial highlights

• Total revenues declined 2% year-over-year in Q4 and 1% for the full year, in line with guidance; Q4 revenues were $1.2 billion and full-year revenues $5.0 billion.

• Q4 net loss was $1 million ($(0.01) per share), improved from a $23 million loss last year; full-year net income was $155 million ($3.20 per diluted share), down from $173 million ($3.43 per share) in 2024.

• Adjusted earnings per diluted share was $4.73 for the year, at the top end of guidance.

• Adjusted EBITDA for 2025 was $425 million (8.5% margin), with free cash flow of $234 million, up 16% year-over-year and a 55% conversion ratio.

• Insurance Services revenue per average co-employed WSE grew 9% as health fee increases were passed through.

Outlook and guidance

• 2026 revenue expected in the range of $4.75B–$4.9B, impacted by lower starting WSE base and elevated Q1 attrition.

• Professional Services revenue forecasted at $625M–$645M, with double-digit ASO growth offset by HRIS decline.

• Insurance cost ratio guidance tightened to 90.75%–89.25%, reflecting stable cost trends.

• Adjusted EBITDA margin forecasted at 7.5%–8.7%; adjusted EPS at $3.70–$4.70.

• Diluted net income per share guidance: $2.15–$3.05.